Journal article
Prospective randomized controlled blinded clinical trial evaluating biomarkers of acute kidney injury following 6% hydroxyethyl starch 130/0.4 or Hartmann's solution in dogs
Journal of Veterinary Emergency and Critical Care, Vol.31(3), pp.306-314
2021
Abstract
Objective: To evaluate the effect of 6% hydroxyethyl starch (HES) 130/0.4, compared with a Hartmann's solution control (CRYST), on urine biomarkers of acute kidney injury (AKI) in dogs prescribed a fluid bolus.
Design: Randomized, controlled, blinded clinical trial January 2018 to February 2019.
Setting: University teaching hospital.
Animals: Forty client‐owned dogs.
Interventions: Dogs prescribed a fluid bolus were randomized to receive at least 10 mL/kg of HES or CRYST with clinicians and investigators blinded to fluid type. Study fluid was used for further boluses as required in the following 24 hours, to a limit of 40 mL/kg total, after which fluid administration was open‐label.
Measurements and Main Results: Urine was collected prior to and 6, 12, and 24 hours after the first study fluid bolus. Urine concentrations of AKI biomarkers: neutrophil gelatinase‐associated lipocalin (NGAL), cystatin C, kidney injury molecule‐1 (KIM), clusterin, and osteopontin were measured using a magnetic bead multiplexed assay. Osmolality‐indexed biomarker concentrations were compared between groups over time with linear mixed‐effects models, with P < 0.05 considered significant. The mean volume of study fluid administered was not significantly different between groups (HES: 23.1 mL/kg, CRYST: 25.9 mL/kg; P = 0.47, t‐test). There were no significant differences between groups in change over time of osmolality‐indexed urine concentrations of NGAL (P = 0.91), cystatin C (P = 0.95), KIM (P = 0.77), clusterin (P = 0.63), or osteopontin (P = 0.91). The maximum Veterinary Acute Kidney Injury (VAKI) score up to 7 days during hospitalization (P = 1.0) and in‐hospital mortality (P = 0.49) were not significantly different between groups, as compared by Fisher's exact test.
Conclusions: There were no differences in change over time of urine AKI biomarkers in dogs treated with 10 – 40 mL/kg HES or CRYST over 24 hours. Larger clinical trials with patient‐centered outcomes are required to investigate the safety of HES in dogs.
Details
- Title
- Prospective randomized controlled blinded clinical trial evaluating biomarkers of acute kidney injury following 6% hydroxyethyl starch 130/0.4 or Hartmann's solution in dogs
- Authors/Creators
- C.J. Boyd (Author/Creator) - Murdoch UniversityC.R. Sharp (Author/Creator) - Murdoch UniversityM.A. Claus (Author/Creator) - Murdoch UniversityA.L. Raisis (Author/Creator) - Murdoch UniversityG. Hosgood (Author/Creator) - Murdoch UniversityL. Smart (Author/Creator) - Murdoch University
- Publication Details
- Journal of Veterinary Emergency and Critical Care, Vol.31(3), pp.306-314
- Publisher
- Wiley
- Identifiers
- 991005543863707891
- Copyright
- © 2021 Veterinary Emergency and Critical Care Society
- Murdoch Affiliation
- School of Veterinary Medicine
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
82 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.154 Assisted Ventilation
- 1.154.360 Procalcitonin
- Web Of Science research areas
- Veterinary Sciences
- ESI research areas
- Plant & Animal Science